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Abstract 
 
Three-dimensional (3D) biodegradable composite porous scaffolds made of a 
biopolymer matrix (chitosan) and a bioactive glass (FastOs®BG-Z4) were fabricated via 
freeze drying as guides for nerve tissue engineering applications. For this purpose, chitosan 
was dissolved in aqueous solutions of lactic acid (LA, 1 wt.%) to reach a final 
concentration of 2 wt.%. Subsequently FastOs®BG-Z4 in powder form was added to 
chitosan solution in a chitosan/Fasto®BG-Z4 weight ratio of 50/50. The 
Chitosan/FastOs®BG-Z4 systems were cross-linked via adding different concentrations 
(0.01, 0.05 and 0.5 wt.%) of two kinds of cross-linking agents, genipin, a natural 
component, and glutaraldehyde, a synthetic agent, to stiffen the chitosan network. The final 
mixtures were then frozen at two temperatures, 20ºC and 80ºC followed by freeze-
drying to obtain porous scaffolds. 
For achieving the optimal Chitosan/FastOs®BG-Z4 scaffolds, the influences of adding 
FastOs®BG-Z4 powder and/or different amounts of crosslinking agents on the rheological 
properties of chitosan/LA solutions were firstly investigated by rheological measurements. 
The results showed that a strong and stable gel could not be obtained even when the 
highest amount of cross-linking agents (0.5 wt.%) was added to the 2 wt.% chitosan 
solution, while effective cross-linking occurred in the presence of FastOs®BG-Z4 powder. 
Therefore, it was concluded that FastOs®BG-Z4 plays an active role on chitosan 
complexation. The positive interactions between chitosan and the surface of FastOs®BG-
Z4 particles and/or the ionic species leached out to the solution needs to be further 
investigated in future work. 
The microstructural features of porous scaffolds were investigated by scanning electron 
microscope (SEM), and the porosity assessment was made by ethanol replacement method. 
The mechanical properties of porous scaffolds were investigated under 
compression/swelling tests with samples immersed in phosphate-buffered saline (PBS) 
solution. In vitro degradation tests were also performed by immersing the samples in 
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phosphate-buffered saline (PBS) solution for 2 months tests and the degradation degree 
was evaluated through the undergone weight changes.  
The results showed some common features among genipin or glutaraldehyde as cross-
linking agents: increasing their amounts from 0.01 to 0.5 wt.% led to reductions in gelling 
time, porosity fraction, swelling and degradation rate, while cross-linking degree increased. 
However, their effects on pore size and compression strength of the scaffolds diverged. For 
genipin pore size decreased and consequently the compression strength increased, while 
for glutaraldehyde pore size always increased with added amounts, but compression 
strength was improved with concentration increasing from 0.01 to 0.05 wt.%, decreasing 
when the added amount was further increased to 0.5 wt.%.  
Moreover, 20ºC was selected as the most suitable freezing temperature when 
considering the porous microstructural features and the intended applications. 
  
 v 
 
Resumo 
 
A presente tese relata acerca do fabrico e caracterização de compósitos porosos 
tridimensionais (3D) biodegradáveis baseados em quitosano, como matriz biopolimérica, 
carregada com partículas de um vidro bioativo (Fastos®BG-Z4). Para este efeito, o 
quitosano foi dissolvido em solução aquosa de ácido láctico (LA, 1% em peso) até atingir 
uma concentração final de 2% em peso. Subsequentemente o Fastos®BG-Z4 em forma de 
pó foi adicionado à solução de quitosano em uma proporção em peso de quitosano/ 
Fastos®BG-Z4 de 50/50. Os sistemas quitosano/Fastos®BG-Z4 foram reticulados por meio 
de adição de diferentes percentagens em peso (0.01, 0.05 e 0.5) de dois tipos de agentes de 
ligação cruzada, um componente natural, genipin, e um agente sintético, glutaraldeído. As 
misturas finais foram então reticuladas a 60ºC seguido de congelamento a duas 
temperaturas diferentes, 20ºC e 80ºC. O gelo foi depois sublimado por liofilização de 
modo a obter matrizes porosas para aplicações como guias em engenharia de tecidos 
nervosos periféricos. 
Com vista à optimização do processo de fabrico e das propriedades das estruturas 
porosas de suporte (andaimes) de quitosano/Fastos®BG-Z4, estudaram-se os efeitos da 
adição do Fastos®BG-Z4 em pó e/ou de diferentes quantidades de agentes de reticulação 
nas propriedades reológicas das soluções de LA/quitosano. Os resultados mostraram a 
impossibilidade de obter de um gel de quitosano suficientemente forte e estável mesmo 
quando a quantidade mais elevada de agentes de reticulação (0.5% em peso) foi adicionada 
à solução de quitosano, em contraste com o que aconteceu com a adição do pó de 
Fastos®BG-Z4 na ausência de outros agentes de reticulação. Esta descoberta permitiu 
concluir que o Fastos®BG-Z4 desempenha um papel activo na complexação do quitosano. 
As interacções positivas entre o quitosano e a superfície das partículas do Fastos®BG-Z4 
e/ou as espécies iónicas lixiviadas para a solução precisam de ser melhor investigadas no 
futuro.  
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As características microestruturais dos materiais porosos foram investigadas por 
microscopia electrónica de varrimento (SEM), e a porosidade foi determinada pelo método 
de substituição de etanol. As propriedades mecânicas dos compósitos porosos imersos em 
solução (PBS) de solução salina tamponada com fosfato foram investigadas através de 
testes de compressão/inchamento. Realizaram-se também testes de degradação in vitro por 
imersão das amostras na mesma solução de PBS durante 2 meses, e o grau de degradação 
foi avaliado através das alterações de peso sofridas pelas amostras. 
Os resultados mostraram algumas características comuns entre o genipin e o 
glutaraldeído como agentes de reticulação: o aumento das quantidades adicionadas 
(0.010.5% em peso) levou a reduções no tempo de gelificação, na fracção de porosidade, 
no grau de inchamento, e na taxa de degradação, enquanto o grau de reticulação aumentou. 
No entanto, os seus efeitos sobre o tamanho dos poros e a resistência à compressão dos 
suportes porosos divergiram. O tamanho de poro diminuiu no caso do genipin, o que se 
traduziu em consequentes aumentos da resistência à compressão; enquanto o tamanho dos 
poros aumentou sempre com as quantidades adicionadas no caso do glutaraldeído, pelo que 
só foram registadas melhorias na resistência à compressão na gama de concentrações entre 
0.010.05% em peso, diminuindo quando a quantidade adicionada foi aumentada para 0,5 
% em peso. 
Verificou-se ainda que a temperatura de 20ºC era a que permitia obter as 
microestruturas porosas mais adequadas para as aplicações almejadas. 
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1.1 Tissue Engineering 
 
Nowadays, the tissues and/or organs for transplantation mainly come from donations 
which, however, cannot meet the clinical needs as a result of several shortcomings of this 
treatment such as longer operation to remove tissue from the donor site, the quality and 
quantity of tissue available for grafting, the risk of immune response and the transmission 
of viral and prionic diseases and infections from the donor, as well as the insufficient 
number of suitable donors available. In some cases permanent prostheses may be used to 
restore partial function to the injured organ. However, the artificial nature of prostheses 
causes several problems, which are considered to be of less importance in comparison to 
regeneration of the injured organ. In order to overcome the limitations of transplantation 
and prosthesis, a new interdisciplinary field called tissue engineering was greatly 
developed and artificial tissues and organs have been fabricated in vitro along the last two 
decades [1] [2]. 
The first tissue engineering definition was made in 1988 at National Science Foundation 
meeting as “The application of the principles and methods of engineering and the life 
science toward the fundamental understanding of structure-function relationships in normal 
and pathological mammalian tissue and the development of biological substitutes to 
restore, maintain or improve functions” [3]. The innovative approach of tissue engineering 
is to seed isolated cells with tissue inducing substances, such as growth and differentiation 
factors, on a scaffold which mimics the extracellular matrix (ECM) and acts as a cell 
attachment, proliferating, migrating and functioning environment (Figure 1.1) [3]. 
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Figure  1.1. Diagram of tissue engineering approach [3]. 
 
 
One of the principal methods in tissue engineering involves the use of porous scaffolds 
to support and guide the in-growth of cells. Tissue scaffolds must be biocompatible, 
biodegradable, bioresorbable, and sterilizable. The scaffold must provide a number of 
properties and functionalities, including: (i) enough mechanical strength in order to 
facilitate in vitro handling and withstand the in vivo environment; (ii) sustaining cell 
function and provide an environment suitable for cellular growth; (iii) contain suitable 
surface properties (wettability, stiffness, and compliance) to support cell attachment, 
proliferation and differentiation. The degradation products should be biocompatible, non-
toxic, and transportable out of the body [4]. Additionally, the pore architecture of scaffolds 
has been shown to have a significant effect on physical properties and cellular activities. It 
has been hypothesized that the pore diameter must be large enough to allow infiltration of 
the cells towards the centre of the scaffold, whilst being small enough to present sufficient 
ligand density for cellular attachment. The optimal pore size is dependent on both the cell 
type and scaffold material [2]. Lee [5] proposed a minimum pore size of 150 m for hard 
tissue and 200–250 m for soft tissue ingrowth. 
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1.2 Objectives 
 
The aims of this project are (a) developing 3D biodegradable composite porous 
scaffolds made of chitosan and bioactive glass (FastOs®BG-Z4) as guides for peripheral 
nervous tissue regeneration; (b) microstructural and mechanical characterization of the 
prepared scaffolds. For this purpose, Chitosan was dissolved in aqueous solutions of lactic 
acid (LA) to which powdered FastOs®BG-Z4 bioactive glass was added together with 
different amounts of crosslinking agents (glutaraldehyde and genipin) to reticulate the 
chitosan. The final mixtures were reticulated at suitable temperature and then frozen at two 
different temperatures (20ºC and 80ºC) followed by freeze-drying to obtain porous 
scaffolds.  
For achieving the optimal chitosan/FastOs®BG-Z4 scaffolds, the dependence of the 
rheological properties of chitosan/LA solutions with fixed chitosan/FastOs®BG-Z4 ratio 
(50:50) and different amounts of cross-linking agents (0.01, 0.05, 0.5 wt.% related to the 
dry weight of chitosan) will be firstly investigated. The effects of cross-linking agents and 
their concentrations on gelation time, and on the physical and structural features of 
scaffolds (pore size, pore size distribution, compressive strength, swelling and degradation 
behaviours) will be investigated. 
 
1.3  Thesis Outline 
 
This dissertation consists of six chapters. The present chapter gives a short general 
introduction to the theme, presents the main objectives of this research work, and outlines 
the content of the different parts of the document. The second chapter gives a detailed 
account about the state of the arte in this specific area of human nervous system, nerve 
injuries and regeneration materials/approaches. The starting materials and reagents, the 
experimental procedures used in the fabrication of the polymeric/composite 3D porous 
scaffolds and for assessment their relevant properties are described in chapter 3. The 
experimental results obtained are presented and discussed in chapter 4. Chapter 5 
summarises the findings and the main conclusions that could be drawn from all 
experiments. Chapter 6 indicates research directions to further explore the most exciting 
aspects of the present work. Finally, the document ends with a list of updated bibliographic 
references cited along the text.  
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2.1 Nerve Tissue, Injuries and Regeneration 
 
The human nervous system is classified into two systems, central nervous system (CNS) 
and the peripheral nervous system (PNS). The CNS includes the brain, spinal cord, optic, 
olfactory and auditory systems. Peripheral nerves are cord-like structures containing 
bundles of nerve fibres that carry information from regions of the body to the spinal cord 
(and vice versa). Peripheral nerves have a tough outer layer of connective tissue that 
surrounds discrete groups of miniscule fibres, called “axons,” each originating from its 
own nerve cell (Figure 2.1) [6] [7].  
Endoneurium surrounds individual axons and their Schwann cell sheaths and is 
composed predominantly of oriented collagen fibres. Next, the perineurium, formed from 
many layers of flattened cells (i.e., fibroblasts) and collagen, surrounds groups of axons to 
form fascicles. Finally, epineurium, an outer sheath of loose fibrocollagenous tissue, binds 
individual nerve fascicles into a nerve trunk [6] [7]. 
 
 
 
Figure  2.1. Anatomical overview of the PNS [6]. 
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The spinal cord is composed of dendrites, axons, and cell bodies (Figure  2.2). The 
centre of the spinal cord, a butterfly-shaped region referred to as grey matter, contains the 
cell bodies of excitatory neurons, as well as glial cells and blood vessels. The grey matter 
is surrounded by white matter, which helps to protect and insulate the spinal cord. White 
matter consists of axons and glial cells [6] [7]. 
 
 
 
Figure  2.2. Figure Anatomy overview of the spinal cord [1]. 
 
 
Injuries in the central nervous system have only a very limited capacity to heal, because 
nerve regeneration tends not to occur. In contrast, peripheral nerves have a remarkable 
capacity for regeneration. Even completely severed peripheral nerves, if repaired promptly, 
can regrow, allowing the patients to enjoy complete or nearly complete recovery in many 
cases [6] [7]. 
Peripheral nerves are fragile and easily damaged. A peripheral nerve, when severed, is 
capable of a significant amount of regeneration. Peripheral nerves are discrete trunks filled 
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with sensory and motor axons, and support a number of cell types, such as Schwann cells 
and fibroblasts [6] [7]. The peripheral nerve trunk can be considered as a protective 
structure for axons. The most popular approach in peripheral nerve tissue engineering 
involves in vivo implantation of artificial scaffolds and substrates that will guide naturally 
regenerating axons to the distal segment.  
As described by Seddon in 1975 [8], there are three different classifications for 
peripheral nerve injuries: (1) neuropraxia which is the lowest degree of nerve injury in 
which the nerve remains intact but signalling ability is damaged, (2) axonotmesis which is 
the second class in which the axon is damaged but the surrounding connecting tissue 
remains intact, (3) neurotmesis or transection injuries where the nerve trunk is completely 
interrupted, especially those resulting in large neural gaps, may have a devastating impact 
on patients, quality of life, and in these cases reconstructive surgery is required as a 
therapeutic management to achieve nerve regeneration and function restoration. In 
consequence, peripheral nerve repair represents a unique challenge and opportunity to 
clinical and translational neurosciences [9]. 
 
2.2 Current Clinical Approaches for Treating Nerve Injuries 
 
It is commonly accepted that physical guidance of axons is a vital component of nerve 
repair. In 1960s, Millesi [6] determined that the use of nerve grafts reduced tension on the 
damaged nerves in many cases and further enhanced functional recovery. Later research 
demonstrated that biochemical signals as well as physical guidance are critical for nerve 
regeneration [7]. 
For peripheral nerve injury, treatment typically consists of either direct end-to-end 
suture of the damaged nerve ends (Figure  2.3) or the use of an autologous nerve graft. 
Performing an end-to-end suture can repair small defects or gaps in the nerve. For longer 
nerve gaps, this surgical approach would induce tension of the suture site, inhibiting the 
nerve regeneration and promoting necrosis of the nerve stumps. Thus, for a larger nerve 
defect, an autologous nerve graft that is harvested from another site in the body is used to 
span the injury site. Disadvantages of this technique include loss of function at the donor 
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site, the need for multiple surgeries and the differences between the donor and the receptor 
nerve diameter, compromising the nerve regeneration [6]. 
For central nervous system injury, and particularly spinal cord injury, clinical treatment 
is less promising. Unfortunately, there is currently no treatment available to restore nerve 
function. After swelling from the injury subsides, patients begin a long period of 
rehabilitation during which time they train remaining nerves to compensate for the loss due 
to injury [1] [3]. 
 
 
 
Figure  2.3. Perineural end-to-end suture of the peripheral nerve fascicles after a neurotmesis injury [6]. 
 
 
2.3 Challenges and Bioengineering Strategies for Nerve Repair 
 
In the PNS, the challenge is to find an alternative to the autologous nerve graft and thus 
eliminate the need for two surgeries and the removal of tissue from the patient. Thus, 
bioengineering strategies for the PNS have focused on developing alternative treatments to 
the nerve graft (e.g., nerve guidance channels), especially for larger defects, and improving 
recovery rates and functional outcome. Many researchers are presently focusing efforts on 
creating physical or chemical pathways for regenerating axons [6] [7]. 
The CNS is a greater challenge for new therapies. The ability of spinal nerves to 
regenerate was not decisively shown until 1980, and it was not until after this time that 
research in this area rapidly developed. In addition, results from various studies have been 
controversial and complicated. These challenges provide fertile ground for the 
development of therapies and devices to enhance regeneration [6].  
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2.4 Neural Tissue Engineering 
 
Nerve tissue engineering (NTE) offers great opportunities to neuroscientists and 
surgeons who have been collaborating to develop tissue engineered nerve grafts [9]. It is 
one of the most promising methods in biomedical engineering for restoring central nerve 
systems in humans and for repairing or replacing the function of defective or damaged 
tissues or organs. Nerve tissue repair is a prized treatment concept in human health care, 
because it has a direct impact on the quality of life [10]. Tissue engineered nerve grafts are 
typically composed of a physical scaffold with the introduction of support cells and/or 
growth factors or other biomolecular components [9]. 
 
2.5 Neural Scaffolds 
 
The physical scaffold of tissue engineered nerve grafts, shortly called the neural 
scaffold, serves to: (1) direct axons sprouting from the proximal to distal nerve stump; (2) 
maintain adequate mechanical support for the regenerating nerve fibres; (3) provide a 
conduit channel for the diffusion of neurotropic and neurotrophic factors secreted by the 
proximal nerve stump and a conduit wall for the exchange of nutrients and waste products; 
(4) obviate the infiltration of fibrous scar tissue that hinders axonal regeneration; and (5) 
create an optimal microenvironment (niche) for nerve regeneration through the 
accumulation and release of exogenous and endogenous biochemical effects. For the sake 
of clinical use, the neural scaffold is hoped to be easy to fabricate and sterilize, and simple 
to implant in the body by microsurgical techniques. Up to now, a diverse array of natural 
or synthetic biomaterials, together with well-defined fabrication techniques, has been tried 
to prepare neural scaffolds that possess different structures, in which tubular nerve 
guidance conduit (NGC) is the basic structure [9].  
 
2.5.1 Requirements of an Ideal Scaffold 
 
An ideal neural scaffold has to satisfy many biological and physicochemical 
requirements, among which biocompatibility, biodegradability, permeability, 
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biomechanical properties, and surface properties are the major concerns. These required 
properties are mainly determined by the scaffold material and scaffold structure [9].  
Figure  2.4 shows the various characteristics desired for an ideal scaffold for neural 
regeneration [10]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.4. Ideal properties of a scaffold for neural regeneration [10]. 
 
2.5.1.1 Biocompatibility 
 
The biocompatibility of neural scaffolds can be evaluated from three important aspects: 
(i) blood compatibility, (ii) histocompatibility, and (iii) mechanical compatibility. Blood 
compatibility requires that the scaffold in contact with blood does not induce hemolysis, or 
destroy blood components, or lead to coagulation and thrombus formation. 
Histocompatibility means that the scaffold has no toxic side effects on the surrounding 
tissues, especially neither teratogenicity nor gene mutation, while the surrounding tissues, 
in turn, do not induce corrosive effects or immune rejection on the scaffold. Mechanical 
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compatibility focuses on the matching of mechanical properties between the scaffold and 
nerve tissues [9]. 
 
2.5.1.2 Biodegradability 
 
In addition to biocompatibility, an ideal scaffold has to possess a controllable ability to 
degrade in vivo. The tuneable degradation kinetics should match the rate of nerve 
regeneration. The ideal neural scaffold should remain intact for the time axons need to 
regenerate across the nerve gap and then degrade gradually with minimal swelling and 
foreign body reaction [9]. 
 
2.5.1.3 Permeability 
 
As a soft tissue engineered product, a neural scaffold must have a sufficient 
permeability for nutrient and gas exchange, including the exchange of fluids between the 
regeneration environment and the surrounding tissues, avoiding the build-up of pressure 
due to fluid retention. Different fabrication techniques affect the permeability by altering 
the porous structure of neural scaffolds, and hydrophilic property of the scaffold material is 
another critical factor responsible for the permeability of neural scaffolds [9]. 
 
2.5.1.4 Biomechanical Properties 
 
Sufficient mechanical strength needs to be considered when designing ideal neural 
scaffolds. A neural scaffold must be flexible to allow bending without kinking as well. It is 
important to make the right balance between the flexibility and hardness, because too stiff 
scaffolds are easy to cause dislocation, and too flexible scaffolds fail to support axonal 
regeneration [9] [11]. 
 
2.5.2 Materials Used for Neural Scaffolds 
 
Table 2.1 provides a summary of materials in use or under investigation for nerve repair 
applications [6] [7]. 
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Table  2.1.Nerve grafts and nerve conduit materials [6] [7]. 
Autologous tissue grafts 
1. Nerve grafts (gold standard) 
2. Vein grafts  
3. Muscle grafts  
4. Epineurial sheaths  
5. Tendon graft 
Nonautologous/acellular grafts 
1. Immunosuppression with allografts  
2. Acellular allografts and xenografts 
 Thermal decellularization  
 Radiation treatment  
 Chemical decellularization  
3. Small intestinal submucosa (SIS)  
4. Human amnion  
Natural-based materials 
1. ECM protein-based materials 
 Fibronectin  
 Laminin  
 Collagen  
2. Hyaluronic acid-based materials  
3. Fibrin/fibrinogen  
4. Chitosan 
5. Other materials (alginate, agarose, etc.)  
Synthetic materials 
1. Biodegradable synthetic materials 
 Poly(lactic acid) (PLA) 
 Poly(lactic-co-glycolic acid) PLGA 
 Poly(caprolactone) 
 Poly(organo)phosphazene  
 Poly(3-hydroxybutyrate)  
 Poly(ethylene glycol) “glue”  
 Biodegradable glass  
2. Electrically active materials 
 Piezoelectric  
 Electrically conducting  
3. Nonbiodegradable synthetic materials 
 Silicone 
 Gore-Tex or ePTFE 
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2.5.2.1 Natural Polymers 
 
The selection of biomaterials is very important for the fabrication of neural scaffolds. A 
wide variety of biomaterials has been attempted, which are of either natural or synthetic 
origin. Natural polymers, such as chitosan, alginate, and especially collagen and fibrin, due 
to their structural similarity with the neural structure, and properties such as cell 
attachment, growth and proliferation, have more advantages than synthetic polymers, but 
their low mechanical properties and their tendency to swell is still a problem to overcome 
to foster the widespread use of such materials. However, designs with small nerve gaps 
have been responsive [12] [13]. Biodegradable nerve guides must be preferred since no 
foreign body material will be left in the host after the device has fulfilled its task [12]. 
 
2.5.2.1.1 Collagen and Other ECM Components 
 
Collagen is the major component of the extracellular matrix and is known to promote 
cellular proliferation and tissue healing. Among the most promising biomimetic 
biomaterials for nerve regeneration, collagen proved to lead to functional recovery similar 
to nerve autografts in experimental animal models. Conduits derived from biologic 
molecules like collagen have demonstrated improved regeneration [14] [15]. Gelatin, 
derived from denatured collagen, is also the first biodegradable material examined for 
preparing neural scaffolds. Other ECM molecule-derived materials, for example, laminin 
and fibronectin, are also used for the fabrication of neural scaffolds [9].  
 
2.5.2.1.2 Alginate 
 
Alginate, commonly purified from seaweed, is a naturally occurring copolymer [9]. 
Prang et al. [16] have assessed the capacity of alginate gels to promote directed axonal 
regrowth in the injured mammalian central nervous system. The alginate scaffolds also 
promoted adult peripheral nerve survival and highly oriented axon regeneration. This was 
the first instance of using alginates to produce anisotropic-structured capillary gels, so 
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further studies are needed to investigate the long-term physical stability of the alginate 
scaffolds, because central nervous system axon regeneration can take many months to 
occur. 
 
2.5.2.1.3 Polysialic Acid 
 
Polysialic acid (PSA) is a relatively new biocompatible and bioresorbable material for 
artificial nerve conduit. PSA shows stability under cell culture conditions and allows for 
degradation induced by enzymes. It has also been discovered recently that PSA is involved 
in steering processes like neuritogenesis axonal path finding, and neuroblast migration. 
Animals (adult female Sprague–Dawley rats) with PSA genetically knocked out express a 
lethal phenotype which has unsuccessful path finding, ie, the nerves connecting the two 
brain hemispheres are aberrant or missing. Thus, PSA is vital for proper nervous system 
development [12]. 
 
2.5.2.1.4 Chitin and Chitosan 
 
Chitin is the second most abundant polysaccharide found in nature next to cellulose, and 
can be isolated from the outer shell of crustaceans, insect exoskeletons, and fungal cell 
walls. Chitin is extensively applied in a wide range of biomedical fields [9]. Chitins and 
modified chitins exert a number of beneficial actions, such as: (1) they stimulate 
macrophages by interacting with receptors on the macrophage surface (2) they stimulate 
macrophages to produce cytokines and other compounds that confer nonspecific host 
resistance against bacterial and viral infections, and antitumor activity [17]. The ideal 
structure of chitin is a linear polysaccharide of β (1→4)-2-acetamido-2-deoxy-D-
glucopyranose, where all residues are comprised entirely of N-acetyl-glucosamine residues 
are fully acetylated. The ideal structure of chitosan, the principal derivative of chitin, is a 
linear polymer of β (1→4)-2-amino-2-deoxy-D-glucopyranose, where all residues are 
comprised entirely of N-glucosamine residues or are fully deacetylated. Figure  2.5 is 
showing the ideal chemical representation of chitin and chitosan [18]. 
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Figure  2.5. Ideal chemical representation of chitin and chitosan [18]. 
 
 
However, the traditional sources of chitin and chitosan are not in fact 100% acetylated 
or deacetylated. They exist as a co-polymer of N-acetylglucosamine and glucosamine, as 
represented in Figure  2.6. The difference between chitin and chitosan is their acetyl 
content. Chitin is made up of more than 50% (more commonly 70-90%) acetamido groups 
while chitosan commonly having 70-90% amino groups. The main parameters influencing 
the chemical characteristics of chitosan are its degree of acetylation that could be within 
the range of 30-95%, and molecular weight, which can vary from 300 to over 1000 kDa 
[18] [19] [20]. 
 
 
 
Figure  2.6. Chemical structural representation of chitin and chitosan illustrating the copolymer 
character of the biopolymers [18]. 
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Chitosan is highly bioactive, biodegradable and biocompatible; so, it is widely used in 
biomedical applications, such as skin substitutes, wound healing, nerve regeneration, gene 
delivery, cartilage and bone tissue regeneration [18]. Chitosan has quite positive effects on 
the nerve regeneration. It has been showed that when chitosan is used, it facilitates nerve 
healing and improves the nerve differentiation and growth. It also shows antifungal, 
antitumoral, anticholesteremic, antibacterial and antimicrobial characteristics because the 
cationic moieties of chitosan molecules can interact with anionic cell wall of 
bacteria/micro-organisms and rupture their cell wall that reduces the bacteria attachment 
and survivability [20] [21] [22]. 
Chitosan is insoluble in neutral or basic pH solutions, but soluble in acidic solutions (< 
pH 6.5), because of presence of primary amine groups which make chitosan a cationic 
polyelectrolyte (pKa ~ 6.5) and allow it to be coupled covalently to the various 
biomolecules, along with its other primary and secondary hydroxyl functional groups [21] 
[23]. 
 
2.5.2.2 Synthetic Polymers  
 
In addition to naturally derived biopolymers, synthetic polymers constitute another class 
of promising biomaterials for fabricating neural scaffolds due to their tuneable chemical 
and physical properties [9].  
Synthetic materials are attractive because their chemical and physical properties (e.g., 
degradation rate, porosity, mechanical strength) can be specifically optimized for a 
particular application [7] [12]. In some cases, synthetic biomaterials are cheaper than 
natural ones, can be produced in larger quantities with uniform properties and have longer 
shelf life [11]. However, the biocompatibility of synthetic materials poses a challenge 
because the body’s inflammatory response can vary considerably from one material to 
another. In addition, some synthetic materials that are tolerated by the body’s immune 
system are unfortunately incompatible with cell adhesion and tissue repair. These materials 
are often modified to render them more “cell friendly” [7] [12]. 
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To select an appropriate synthetic material, there are several general properties that all 
nerve guidance channels should possess: (1) they must be readily formed into a conduit 
with desired dimensions, (2) they must be sterilizable, (3) they must be tear resistant, and 
(4) they must be easy to handle and suture. Permanent materials pose a higher risk for 
infection, are more likely to provoke a chronic inflammatory response, and have the 
potential to compress the nerve over time. Thus, a nerve guide that degrades as the nerve 
regenerates is preferred. Additionally, guidance channels should be pliable, but should 
maintain their shape and resist collapse during implantation and over the time course for 
regeneration. Research has also shown that guidance channels should be semipermeable 
and should have a smooth inner wall. Properties of the ideal nerve guidance channel are 
shown in Figure  2.7 [7] [12]. 
 
 
 
Figure  2.7. Properties of the ideal nerve guidance channel [7]. 
 
 
So the factors that control material selection include biocompatibility, biodegradability, 
mechanical integrity and controllability during nerve growth, implantation and sterilization 
[12]. 
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2.5.2.2.1 Non-absorbable Synthetic Polymers 
 
Beginning in the early 1980s, replacement surgery using artificial nerve conduits made 
from non-absorbable materials, such as silicone Figure  2.8), has been in use for the 
treatment of severed nerves. All these reports, however, are of studies demonstrating 
recovery in morphologic continuity of a nerve with an extremely small gap of about 10 
mm in small laboratory animals, and recovery of motor function has rarely been achieved. 
The outcome is in no way superior to that of nerve autografting in any of the reported 
studies. Elastomer hydrogels or porous stainless steel has also been used for nerve 
regeneration. However, these artificial materials have the disadvantages of engendering 
chronic foreign body reaction due to scar tissue formation, inflexibility, and lack of 
stability [12] [14]. 
 
 
 
 
Figure  2.8. Silicone tube for nerve regeneration after a neurotmesis injury [12]. 
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2.5.2.2.2 Absorbable Synthetic Polymers  
 
It became recognized from the latter half of the 1980s onwards that degradable-
absorbable materials are preferable in the body after attaining nerve regeneration. With the 
progress in material synthesis and bridging techniques, artificial nerve guides made of 
absorbable synthetic materials, have been developed. Substances such as polyglycolic acid 
(PGA) and polylactic acid (PLA) or polyhydroxybutyrate are under investigation as 
biodegradable-absorbable synthetic materials for nerve regeneration [12] [14]. Khorasani 
et al. [24] have designed PLLA tubes for nerve regeneration and studied cellular 
investigations and in vitro assessments. These polymers are brittle, and they do not have 
regions permissible for chemical modification. In addition, they degrade by bulk rather 
than by surface, which is not a smooth and ideal degradation process. In an attempt to 
overcome the lack of functionality, free amines have been incorporated into their structures 
from which peptides can be tethered to control cell attachment and behaviour. Other 
biodegradable poly(esters), such as poly(caprolactones), have also demonstrated promise 
for nerve regeneration applications. In addition to poly(esters), biodegradable poly 
(urethane), poly(organo phosphazene), methacrylate-based hydrogels, and poly(3-
hydroxybutyrate) have shown a capacity for guiding regeneration. Biodegradable glass 
tubes have also been studied, but results of pre-clinical studies have not been optimistic 
[12] [14]. 
 
2.5.2.3 Composite Nerve Guides 
 
Composite scaffold materials can be designed from both synthetic and natural polymers 
embedding particles of bioactive and biodegradable inorganic components such as calcium 
phosphates or bioglasses.  
Clinically, type I collagen conduits [25], chitosan [26] [27] [28] and polyphosphoesters 
such as poly (DL-lactide–caprolactone) [29] [30] are popular resorbable biomaterials used 
in nerve tissue repair. However, there is significant scope for improvement with these 
materials.  
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In addition to materials which can interact with the body to improve regeneration, it is 
required to make a balance among mechanical properties, biocompatibility, and controlled 
degradability. Accordingly, composite materials offer significant opportunities for 
investigation [31]. Composites that have combined biodegradable polymers and bioactive 
inorganic phases such as hydroxyapatite (HA) [32] [33], β-TCP [34] [35] or bioactive glass 
[36] [37] [38] have resulted in resorbable scaffolds with tailored biocompatibility and 
improved physical and mechanical properties, especially in hard tissue regeneration. 
Additionally, some of degradation by-products can be clinically beneficial. So, composite 
materials, if properly designed and optimized, may allow the development of scaffolds 
with tailored physical, biological and mechanical properties to suitably match the 
application of peripheral nerve repair [31]. 
Guidance of developing axons involves turning of the motile tip, the growth cone [39], 
and is dependent on extracellular cues, including ionic messengers. Divalent calcium ion 
(Ca2+) is the most widely used messenger which regulates turning (guidance) and extension 
of the growth cone [40] [41]. Zinc (Zn2+) is the second most existing trace element in the 
human body and is required for normal growth and correct immune function [42], it is also 
an effective antibacterial agent [43]. It has also been suggested that Zn2+ may be a valuable 
specific therapy for uremic polyneuropathy and nerve development [42]. From a material 
viewpoint, the synthesis of degradable bioglasses containing these elements is a possible 
way to release controlled levels of these therapeutic ions in controlled levels is possible via 
the synthesis of degradable bioglasses containing these elements [44] [ [45]. Therefore, 
combining such bioglasses with polymers appears as a quite promising strategy to enhance 
the mechanical properties of the scaffolds and their biological responses in vivo.  
Bioactive materials elicit an appropriate biological response when implanted in vivo, 
enabling the formation of bonds between materials and surrounding tissues. Bioactive 
glasses are commonly described as ideal materials for bone tissue regeneration due to their 
ability to promote osteointegration, mesenchymal stem cell differentiation, and promotion 
of growth factor [46]. Bioactive glasses have been used in biological applications since 
Hench described their use the early 70s. There have been interesting research works about 
bioactive glasses in science and biomedical applications over the last two decades, as 
evidenced by the growing number of publications in this field [47]. Bioactive glasses have 
shown tailored therapeutic ion release, primarily in hard tissues. However, as described 
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before, controlled degradation and release of therapeutic ions from these biomaterials may 
also play an important role in soft tissue regeneration such as repairing of peripheral nerve 
gaps [44]. There has been relatively little research on the application of bioactive glasses 
on repairing of peripheral nerve gaps. According to Buting et al. [36], fibres of Bioglass® 
45S5 can form a biocompatible scaffold to guide re-growing peripheral axons in vivo. 
Kehoe [31] has successfully designed a nerve guidance conduit consists of PLGA (lactic to 
glycolic acid mole ratio, 75:25) and a zinc-silicate based bioactive glass and evaluated the 
cytotoxicity and mechanical properties of conduit. Zhang et al. [44] have designed silica-
based glasses (Si–Na–Ca–Zn–Ce system) and investigated composition-structure-property 
relationships in these systems with respect to their potential use as fillers in polymeric 
(PLGA) composite constructs for peripheral nerve regeneration. They have evaluated the 
Ca2+ and Zn2+ release profile for this purpose. Release of such elements, at appropriate 
levels, from peripheral nerve guidance conduits may be advantageous with respect to the 
repair of peripheral nerve discontinuities. 
Goel et al. [45] have designed and developed alkali-free series of bioactive glasses in 
the glass system CaO–MgO–SiO2–P2O5–CaF2 along the diopside (CaMgSi2O6)–
fluorapatite (Ca5(PO4)3F)–TCP (3CaO.P2O5) join. FastOs®BG is a common designation for 
these developed bioactive glasses, which can be doped with some other elements such as 
Sr, Zn, Mn, etc. It was demonstrated that these glasses exhibit high rate of in vitro 
bioactivity, but detailed in vitro cell culture and in vivo tests need to be carried out on this 
bioactive glass in order to prove their efficacy for application in human biomedicine. On 
the other hand, the bioactive glasses having high alkali metal content (sodium and 
potassium) are sensitive to water uptake resulting in swelling and cracking of the polymer 
matrix embedding them in composites [48]. So, it can be concluded that by using these 
alkali-free bioactive glasses embedded in polymer matrix, the rate of swelling and 
degradation of composites can be controlled which is important in nerve tissue 
regeneration. In fact, the resistance to deformation determines whether the conduit can be 
used in vivo due to the various stresses from the surrounding tissue while the resistance to 
swelling protects the regenerated nerve axons from being compressed by the conduit wall. 
The swelling should be moderate [49] [50]. 
Recently, chitosan-based nerve conduits extensively developed to bridge large 
peripheral nerve gaps have achieved considerable success [50] [51] [52] [53] [54]. 
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However, there is currently no research using the combination of chitosan and 
FastOs®BG in nerve tissue repair. Thus, in this study, novel biodegradable composite 
membranes based on chitosan and FastOs®BG doped with 4 mol% Zn (FastOs®BG-Z4) 
were synthesized aiming at nerve regeneration applications. It is hypothesized that 
FastOs®BG-Z4 particles will improve the mechanical properties of the membranes to resist 
muscular contractions and maintain a stable support structure to provide space for nerve 
regeneration. It is also expected that the controlled ionic release from FastOs®BG-Z4 will 
assist in nerve regeneration and in preventing oxidative stress [45].  
 
2.6 Cross-linked Chitosan Scaffolds 
 
For generating chitosan scaffolds, the polymer has to be cross-linked to raise its 
stability. Cross-linking treatments are split into two groups: chemical cross-linking and 
biophysical cross-linking. Chemical methods include the use of various chemical reagents, 
whereas biophysical methods include the use of UV light and dehydrothermal cross-
linking [2].  
Chitosan can be cross-linked either ionically or covalently. As ionic cross-linkers, 
polyanions like triphosphate, citrate or natural polymers like hyaluronic acid or chondroitin 
sulphate are used. In this connection the polyanion can interact with chitosan via 
electrostatic forces to form an ionic cross-linked network. The other possibility is a 
covalently formed network with the amino and hydroxy-groups of chitosan reacting with 
functional groups of cross-linker molecules. Covalently cross-linked networks can be 
formed by genipin, di- or polyaldehydes (glutaraldehyde, oxidised starch and oxidised 
cylcodextrin). Also, carboxylic acids, azides, epoxides, diisocyanates and silanes are 
compounds that have been used as covalent cross-linkers [55] [56]. 
 
2.6.1 Glutaraldehyde 
 
Glutaraldehyde (GT) is one of the most popular cross-linking treatments for biological 
tissues. It is a bifunctional cross-linker, which reacts with chitosan via either a Schiff base 
24 State of The Art 
 
 
reaction, leading to imine functionality (Figure  2.9), and/or through Michael-type adducts 
with terminal aldehydes, leading to the formation of carbonyl groups. Although being 
widely used, GT mediated cross-linking is often cited as being undesirable as it introduces 
cytotoxic aldehyde molecules [57] [58]. 
 
 
 
Figure  2.9. The chemical structure of GT-cross-linked chitosan [57]. 
 
 
2.6.2 Genipin 
 
Genipin (GP) (Figure  2.10) can be obtained from its parent compound, geniposide, 
which is isolated from the fruits of Gardenia jasminoides ELLIS. GP and its related iridoid 
glucosides have been widely used as antiphlogistics and cholagogues in herbal medicine. It 
has been used as a cross-linking agent for the fixation of biological tissues as 
bioprostheses. It can react spontaneously with amino acids or proteins to form dark blue 
pigments. GP is about 500010,000 times less cytotoxic than glutaraldehyde [59] [60] 
[61]. 
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Figure  2.10. Schematic of GP chemical structure [60]. 
 
 
Mi et al. [62] have shown that cross-linking of chitosan membrane using GP reduced its 
tensile strain, swelling ratio and enzymatic degradability. According to Chiono et al. [63], 
chitosan/gelatin blends cross-linked with optimal additions of GP were able to support 
neuroblastoma cell adhesion and proliferation, and cross-linking degree increased with 
increasing the GP amount as a result of higher water stability and mechanical stiffness. 
Sung [64] has shown that differences in cross-linking structure may affect the mechanical 
properties and the bonding characteristics of the graphs to living tissues. 
 
2.7 Fabrication Techniques for Nerve Guidance Conduit 
 
To more accurately mimic natural repair in the body, recent studies have focused on the 
use of various advanced approaches to create complex guidance channels and to combine 
multiple stimuli into a single therapy. With regard to advanced guidance channel 
fabrication, most techniques have focused on creating intricate internal structures that more 
accurately mimic the nerve architecture, such as the inclusion of fibres and channels to 
guide individual nerve fibres. In general, researchers have attempted to improve the neural 
scaffold properties by several novel fabricating techniques such as magnetic polymer fibre 
alignment, injection moulding, solid free-form fabrication, ink-jet polymer printing, 
nanofibre self-assembly, solvent casting and particulate leaching, gas foaming, 
emulsification/freeze-drying, liquid-liquid phase separation, electrospinning, incorporating 
nerve growth factors in the scaffold and improving the wettability of the scaffold surface 
by surface modifications [10] [14]. Each technique is briefly described below. 
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2.7.1 Magnet Alignment and Injection Moulding 
 
Nerve guidance channels have been predominantly fabricated as hollow tubes or as 
porous foam rods because of the ease in manufacturing these devices. For hollow tubes, it 
is known that the body normally generates an oriented fibrin matrix after placement of a 
hollow conduit across a nerve defect, which serves as a critical precursor to axonal 
regeneration. With regard to foam rods, it is questionable whether an amorphous irregular 
structure optimally guides axonal regeneration. Thus, to mimic natural repair in the body 
and to shorten the time required for regeneration, more recent studies have focused on the 
modification of nerve guidance channels with internal matrices of longitudinally aligned 
fibres or channels. These devices often require more advanced processing techniques. As a 
means to provide the necessary matrix alignment and also improve upon processing 
conditions, magnetic fields have been used to orient protein polymers. In a different 
approach, a novel foam-processing technique, utilizing low-pressure injection moulding, 
created highly porous conduits from PLGA with continuous longitudinal channels [10]. 
 
2.7.2 Phase Separation 
 
When using phase separation, a porous structure can be easily obtained by adjusting 
thermodynamic and kinetic parameters. However, because of the complexity of the 
processing variables involved in the phase separation technique, the pore structure cannot 
be easily controlled. Moreover, it is difficult to obtain large pores, which may exhibit a 
lack of interconnectivity [65]. 
 
2.7.3 Gas Foaming 
 
Gas foaming has the advantage of room temperature processing but produces a largely 
nonporous outer skin layer and a mixture of open and closed pores within the centre, 
leaving incomplete interconnectivity. The main disadvantages of the gas foaming is that it 
often results in a non-connected cellular structure within the scaffold [66]. 
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2.7.4 Solvent Casting 
 
Solvent casting is a combination with particulate leaching method, which involves the 
casting of a mixture of monomers and initiator solution and a porogen in a mould, termed 
polymerization, followed by leaching-out of the porogen with the proper solvent to 
generate the pores. It is inexpensive but still has to overcome some disadvantages in order 
to find engineering applications as structures that facilitate either tissue regeneration or 
repair during reconstructive operations [66].  
 
2.7.5 Freeze Drying 
 
Freeze drying technique is based upon the principle of sublimation to fabricate porous 
scaffolds. The typical process would be to dissolve the polymer into a solvent in order to 
form a solution of desired concentration. Then the solution is frozen and solvent will be 
removed by lyophilisation under a high vacuum. In this method, the pore size and porous 
structure can be controlled by the freezing rate, pH, and temperature. However, the small 
pore size formed in this technique is a concern for some applications and also the time 
consuming lyophilisation step [1].  
Generally, the freeze-drying process can be split into two parts: freezing and drying. 
During freezing the temperature of the solution is lowered and a phase change occurs, 
where liquid water is converted into ice crystals. The cooling rate is an important aspect of 
the freezing cycle because it affects the ice crystal formation during freezing. Fast rates of 
cooling have a tendency to produce many small ice crystals. These crystals may not be 
continuous, but they are generally homogeneously distributed throughout the frozen 
solution. A slow rate of freezing will result in a more connected ice crystal structure with 
larger crystals [2]. 
So, to produce large ice crystals, the freezing temperature should be as high as possible 
and the time for crystallization should be extended. To produce smaller crystals, freezing 
should take place under low temperature conditions and the freezing rate should be high in 
order to reduce the time available for ice crystals to grow [67].  
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The next step in the process is drying in which heat is added to the material under a 
vacuum. Under these conditions the ice crystals are sublimated from the solute. The 
sublimated water vapour is then trapped on a condenser, and the process is complete [2]. 
With freeze drying system, two kinds of biomaterials with different properties can be 
combined to produce scaffold structures with good biocompatibility in the inner layer and 
with the desired mechanical strength protruded by the outer layer. The forming precision is 
high, the wall thickness can be controlled, and a tight connection between the two layers 
can be achieved [66]. 
Both homogeneous aqueous solutions and heterogeneous dispersions can be frozen and 
freeze-dried to prepare materials with relatively disordered macroporous structures. 
Alternatively, the freezing process can be performed in a more controlled manner to 
orientate the growth of the ice crystals in one direction. Zhang et al. [67] have described 
developments in the use of directional freezing techniques to produce porous materials 
where the orientation of the crystal growth defines the pore structure. They outline how 
these methods can produce complex composite materials with a range of aligned pore 
architectures. Figure  2.11 shows a schematic diagram of the directional freezing process. 
Ice crystals grow from the bottom [67].  
 
 
 
 
Figure  2.11. Scheme showing the directional freezing process [67]. 
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Particles and polymeric molecules are excluded from the ice and aggregate between the 
growing ice crystals. After the freezing is complete, removal of the orientated ice by freeze 
drying leads to the formation of aligned structures. 
 
2.7.6 Electrospinning 
 
Electrospinning is a simple, unique, and efficient method which has the possibility of 
producing ultrafine multicomposite fibres with spatial orientation and nanodimensions 
with high surface area and controlled pore geometry [68]. A polymer solution or melt is 
drawn from a nozzle by applying a force of gravity or mechanical pressure combined with 
an electric field of high voltage (10–20 kV). When the electric charge overcomes the 
surface tension of the polymer solution droplet, a polymer jet is sprouted, followed by 
solvent evapouration which forms the solid nanofibres [69]. The properties of the 
electrospun fibres such as the diameter, orientation, and porosity influence cell adhesion, 
proliferation and processes such as the transportation of nutrients (e.g. metabolites, 
oxygen) to and from the cells. The orientation of fibres within the engineered scaffold play 
an important role in mimicking the extracellular matrix (ECM) because many tissues in the 
body (e.g., endothelial and nerve cells) have regular oriented architecture, which is 
strongly correlated to their distinguished mechanical properties and particular functions. 
These described factors should be considered while designing and fabricating engineered 
scaffolds for nerve tissue engineering [68]. 
 
2.7.7 Solid Freeform Fabrication 
 
Recently, the emergence of advanced techniques for polymer processing such as solid 
freeform fabrication (SFF) has gained tremendous attention in the bioengineering field 
because of its ability to design of intricate devices for peripheral nerve and spinal cord 
repair. SFF can fabricate 3D porous scaffolds with high degree control microstructure 
directly from a computer model. Some limitations do exist, including the high cost of the 
instrument and the inability to incorporate biological components under some processing 
conditions [6] [70]. 
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Different techniques for the tissue engineering scaffolds fabrication are summarized and 
compared in Table  2.1 [1] [71]. 
 
 
Table  2.1. Comparison of different techniques used for the fabrication of 
scaffolds for tissue engineering applications [1] [72]. 
 
Methods Pore size 
(μm) 
Porosity 
(%) Advantages Disadvantages 
Solvent 
Casting/Particul
ate Leaching 
30-300 20-50 
Controlled porosity, 
pore size, 
inexpensive 
Limited thickness, 
lack of mechanical 
strength, harmful 
organic solvent and 
porogens residue 
Phase 
Separation - - 
Ease to combine with 
other techniques, 
ability to keep the 
activity of 
biomolecules 
Difficulty to precisely 
control scaffold 
morphology 
Freeze Drying <200 <97 
Simplicity of 
utilization, no high 
temperature or 
leaching, highly 
porous structures, 
high 
interconnectivity 
Small pore size and 
long processing time 
Electrospinning - - 
Controllable 
porosity, pore size, 
and fibre diameter 
Limited mechanical 
properties, decreased 
pore size with 
increasing thickness 
Rapid 
Prototyping 40-150 <90 
Excellent controlled 
geometry, porosity, 
good repeatability 
Expensive equipment, 
limited polymer type 
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3.1 Materials 
 
An alkali-free bioactive glass was selected from a series of compositions (mol%): 36.07 
CaO – (19.24 – x) MgO – xZnO 5.61 P2O5 – 38.49 SiO2 – 0.59 CaF2 [45], where x was 
fixed at 4.00 mol% (FastOs®BG-Z4). The synthesis included high-purity powders of SiO2 
(purity >99.5%), CaCO3 (>99.5%), MgCO3 (BDH Chemicals Ltd., UK, purity >99.0%), 
ZnO (Sigma Aldrich, Germany, 99.9+%), NH4H2PO4 (Sigma Aldrich, Germany, >99.0%) 
and CaF2 (Sigma Aldrich, Germany, 325 mesh,>99.9%), as described elsewhere [45]. A 
homogeneous batch (~100 g) obtained by ball milling, was preheated at 900ºC for 1 h for 
decarbonisation and then melted in a Pt crucible at 1550ºC for 1 h in air. The molten glass 
was poured in cold water to obtain a frit, which was then dried and milled in a high-speed 
agate mill, resulting in fine glass powders with mean particle sizes of ~1020 μm 
(determined by light scattering technique; Coulter LS 230, Beckman Coulter, Fullerton, 
CA; Fraunhofer optical model). The amorphous nature of glasses was confirmed by X-ray 
diffraction (XRD) analysis (Rigaku Geigerflex D/Max, Tokyo, Japan; C Series; Cu Kα 
radiation; 2θ angle range 10 – 80; step 0.02 s–1). 
Commercial chitosan with medium molecular weight and a deacetylation percentage 
(DD) of 85% was purchased from Sigma-Aldrich (Germany) and lactic acid (LA) was 
purchased from Fluka (Germany). Glutaraldehyde (50%) was a product of USA and 
genipin was obtained from Challenge Bioproducts (Taiwan). Distilled water was used to 
prepare all the solutions.  
 
3.2 Preparation of Chitosan/FastOs®BG-Z4 Membranes 
 
The chitosan/FastOs®BG-Z4 composites were prepared as schematized in Figure  3.1. A 
1 vol.% lactic acid (LA) solution was firstly prepared in distilled water. Then, a 2 wt.% 
chitosan was added to this 1 vol.% LA solution, which was kept under magnetic stirring 
overnight at 50ºC. The as obtained chitosan solution was filtered through a 150 µm sieve 
and FastOs®BG-Z4 powder was then added in order to have a chitosan:Fastos®BG-Z4 
weight ratio of 50:50. Different amounts of genipin and glutaraldehyde (0.01, 0.05 and 0.5 
wt.% relative to the dry mass of chitosan) were separately added as cross-liking agents for 
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chitosan matrix. The as obtained composite systems were poured into closed special 
moulds to avoid evapouration and left for 20 minutes in an oven at 60ºC to promote 
reticulation. The prepared gels were frozen at 20ºC for 24 h and 80ºC for 4 h to evaluate 
the effect of freezing temperature on the membrane properties. The frozen samples were 
then lyophilized in a freeze-dryer (Labconco, USA) (Figure  3.2) at 50ºC, under vacuum 
(45×103 mbar), for 72 h to obtain porous membranes. Dried membranes were stored in a 
desiccator at room temperature until use.  
 
 
 
Figure  3.1. Schematics of the composite chitosan/FastOs®BG-Z4 membranes preparation process. 
 
 
 
 
Figure  3.2. The freeze dryer system (Labconco, USA) used for 
lyophilization of chitosan-based membranes. 
Lactic acid 
1 vol.% 
Chitosan 
FastOs®BG-Z4  
 
Cross-linker 
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The 50:50 weight ratio composite chitosan:FastOs®BG-Z4 membranes containing 0.00, 
0.01, 0.05 and 0.50 wt.% of genipin (GP) and glutaraldehyde (GT), frozen at 20ºC and 
80ºC, were labelled as shown in Table  3.1.  
 
 
Table  3.1. Codes of composite chitosan/FastOs®BG-Z4 membranes cross-linked with GP and GT 
frozen at 20ºC and 80ºC. 
Chitosan:FastOs®BG 
ratio Genipin (wt.%) 20ºC 80ºC 
50:50 
0.00 GP00-20 GP00-80 
0.01 GP01-20 GP01-80 
0.05 GP05-20 GP05-80 
0.50 GP50-20 GP50-80 
 
Chitosan:FastOs®BG 
ratio 
Glutaraldehyde 
(wt.%) 20ºC 80ºC 
50:50 
0.00 GT00-20 GT00-80 
0.01 GT01-20 GT01-80 
0.05 GT05-20 GT05-80 
0.50 GT50-20 GT50-80 
 
 
3.3 Characterization and Properties Evaluation 
 
3.3.1 Rheological Properties 
 
The effects of adding different amounts of GP or GT (Table  3.1) or FastOs®BG-Z4 
powder alone, and concomitantly with the different amounts cross-liking agents on the 
gelation behaviour of the final mixtures were evaluated under oscillatory tests carried out 
in a C-VOR rheometer (Bohlin Instruments, USA) (Figure  3.3) equipped with cone and 
plate geometry (Ø = 20 mm, angle =1º, gap = 150 µm) at 60ºC. To minimize the effect of 
the water evaporation, a "solvent trap" was used, in order to saturate the surrounding 
sample environment with water. The oscillatory rheological parameters used to compare 
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the viscoelastic properties for all the systems were the storage modulus (Gʹ) and the loss 
modulus (Gʹʹ).  
Preliminary tests were run to determine the linear viscoelastic range in which the 
oscillatory tests would be performed, i.e. the range where response of the sample is within 
the linear viscoelastic region. 
Temperature sweep measurements were also performed for all the systems in order to 
determine the required temperature-time schedule for reticulation to help stipulating the 
experimental conditions to be used in further experiments. Gelation experiments were then 
conducted at a constant frequency (1 Hz) and stress (5 Pa) by recording the variation of the 
elastic modulus (Gʹ) and viscous modulus (Gʹʹ) along the time at a constant temperature of 
60ºC. The gelation time for each system was considered to be the corresponding to the 
respective crossover point of Gʹ and Gʹʹ.  
 
 
 
Figure  3.3. The C-VOR rheometer (Bohlin Instruments, USA) used in this study. 
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3.3.2 FTIR-ATR Spectroscopy Analysis 
 
Fourier transform infrared spectroscopy-Attenuated total reflectance (FTIR Bruker 
Tensor 27) was used to investigate the characteristic functional groups. For this purpose, 3 
samples GP00 (GT00), GP05-20, and GT05-20 (Table 3.1) were selected and tested within 
the wavelength range 300 – 4000 cm−1, using 276 scans and 4 cm−1 resolution. 
 
3.3.3 Microstructure Analysis 
 
The morphology of the chitosan/FastOs®BG-Z4 scaffolds’ cross-sections were observed 
by scanning electron microscopy (SEM, Hitachi, S-4100, Tokyo, Japan, 15-kV 
acceleration voltage). The samples were cut into 5 mm diameter discs and coated with a 
thin layer of a gold-palladium alloy by using sputter coater (Polaron Equipment Limited 
SEM coating unit E5000) before SEM analysis.  
 
3.3.4 Cross-linking Degree Determination  
 
The cross-linking degrees of scaffolds reticulated with GP and GT were determined by 
the ninhydrin (NHN) assay described elsewhere [72] [73]. The NHN solution was prepared 
as follows:  
 
Solution A:  
25 ml distilled H2O containing 1.05 g citric acid (99%), 0.4 g NaOH (≥97%) and 0.04 g 
SnCl2.2H2O (98%); 
 
Solution B: 
25 ml ethylene glycol monomethyl (≥99.5%) containing 1 g NHN.  
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The two solutions were mixed with stirring for 45 min and the final NHN solution was 
stored in a dark bottle.  
Before determination of cross-linking degree, 4 mg of the lyophilized scaffolds from 
each group was heated with 2 ml NHN solution to 100ºC in a water bath for 20 min. The 
solution was then cooled down to 20ºC, diluted with 5 ml of 50% isopropanol, and the 
optical absorbance of the solution at 570 nm was recorded with a spectrophotometer (UV-
210, Hitachi, Japan) (Figure 3.4) using glycine at various known concentrations (1.0, 2.0, 
3.0, 4.0, and 5.0 mg/ml) as standard.  
It is known that, after heating with NHN, the amount of free amino groups in the test 
sample is proportional to the optical absorbance of the solution. The measured 
concentration was divided by the sample weight and multiplied by the sample molecular 
weight to obtain the mole NH2/mole sample. The extent of cross-linking (%CL) for each 
sample was calculated using the following equation: 
 
 %࡯ࡸ	 = (ࡺࡴࡺ	࢘ࢋࢇࢉ࢚࢏࢜ࢋ	ࢇ࢓࢏࢔ࢋ)ࢉ࢕࢔࢚࢘࢕࢒	– 	(ࡺࡴࡺ	࢘ࢋࢇࢉ࢚࢏࢜ࢋ	ࢇ࢓࢏࢔ࢋ)ࢌ࢏࢞ࢋࢊ(ࡺࡴࡺ࢘ࢋࢇࢉ࢚࢏࢜ࢋ	ࢇ࢓࢏࢔ࢋ)ࢉ࢕࢔࢚࢘࢕࢒ × ૚૙૙ 
 
 
where ‘control’ is the mole fraction of free NH2 in non-cross-linked sample 
(chitosan/FastOs®BG-Z4 without GP or GT) and ‘fixed’ is the mole fraction of free NH2 
remaining in cross-linked sample. Each determination was performed in triplicate (n = 3). 
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Figure  3.4. The spectrophotometer (UV-210, Hitachi, Japan) used in this study. 
 
 
3.3.5 Pore Size and Porosity Measurement 
 
The porosity of the chitosan scaffolds was evaluated using cylindrical samples of 2.4 
cm (diameter) × 0.9 cm (height) with the ethanol replacement method described by Yang 
et al. [74]. Porosity (%) was calculated by the following equation: 
 
 
ܲ݋ݎ݋ݏ݅ݐݕ	(%) = 	 ௣ܸ
௧ܸ
× 100 = ݉ଶସ −݉଴
௧ܸ × ߩ × 100 
 
 
where ௧ܸ  is the total volume of the chitosan scaffold (cm
3), ௣ܸ is the pore volume of the 
chitosan scaffold (cm3), ݉ଶସ 	is the weight (g) of the chitosan scaffold after incubation with 
ethanol for 24 h, ݉଴	is the original weight (g) of the chitosan scaffold, and ߩ	is the density 
of ethanol (0.789 g cm3). 
Equivalent circle diameter (ECD) of the pores was calculated by using ImageJ software. 
In brief, the pores were manually picked by built-in drawing functions, and the area (A) of 
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each pore was subsequently measured by using ‘Measure’ function. The pore diameter was 
then calculated according to following formula:  
 
ܦ = 	ඥ4ܣ/ߨ 
 
To validate this measurement statistically, at least three images (100 pores) with the 
same magnification representing different areas of the composite were analysed at each 
condition. 
 
3.3.6 Mechanical Properties 
 
The mechanical properties of composite scaffolds reported in Table  3.1 were 
characterized by using a Universal Testing Machine (Shimadzu, AGS-X STD +250) 
(Figure  3.5). Cylindrical samples with dimensions (diameter = 13 mm ± 0.5 mm, and 
length = 0.9 mm ± 0.5 mm) measured using a digital calliper (J.B.S) were tested to 
investigate the effects of different added amounts of cross-linking agents (GP and GT) on 
compressive strength.   
Since scaffolds for nerve regeneration must be used in the hydrated state, mechanical 
tests were performed in wet samples. So, prior to mechanical tests, the composite scaffolds 
were fully immersed into PBS for 24 h to reach equilibrium swelling as explained in 3.3.7 
section. The excess water on the surface was gently removed by a filter paper.  
The compression load applied during compression test was 5 N, the cross head speed 
was set at 1 mm/min and compressive strengths were measured at strains of 20%, 40%, 
and 60%. The tangent slope of the stress–strain curve, with stress (kPa) on Y-axis and 
deformation (%) on X-axis, was measured at 30% deformation to calculate elastic 
modulus. Measurements were made eight times for each composition and average values 
are reported. 
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Figure  3.5. Universal testing machine (Shimadzu, AGS-X STD +250) used in this study. 
 
 
3.3.7 Water Uptake (Swelling Test) 
 
The swelling ratio is an important index used to evaluate the structural stability of the 
scaffolds. Because chitosan contains hydroxyl and amino groups, it is easily hydrated in 
water. Swelling will affect the structure of the scaffold [46]. 
The swelling properties of chitosan membranes were studied by immersing the 
previously weighted samples (un-cross-linked chitosan/FastOs®BG-Z4, and cross-linked 
ones with the amounts of GP and GT reported in Table 3.1 and frozen at 20ºC and 80ºC) 
in 10 ml phosphate buffered saline solution (PBS) (pH 7.4) at 37ºC for 24 h. 
At predetermined intervals (30 min, 1, 2, 3, 12 and 24 h), the samples were withdrawn 
from the PBS solution, gently dried with a filter paper to remove the water adhered on the 
surface and then weighted. The swelling ratio (SR) of these samples was calculated by 
using the following equation: 
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ܵݓ݈݈݁݅݊݃	ݎܽݐ݅݋	(%) = ൤ ௦ܹ − ௗܹ
ௗܹ
൨ × 100 
 
where ௦ܹ and ௗܹ are the weight of swollen samples at predetermined intervals and dry 
samples, respectively. Each experiment was repeated three times and the average value 
was taken to validate the results. 
 
3.3.8 Weight Loss (Degradation Test) 
 
The in vitro degradation of the samples was evaluated in phosphate buffered saline 
(PBS) solution (pH 7.4) by registering the weight loss evolution with time. The dried 
membranes were cut into small pieces and weighted carefully before in vitro analysis. The 
dried samples were submerged in PBS solution (1:100 w/v) and incubated at 37ºC in an 
incubator (Edmund Bühler GmbH) (Figure  3.6) with constant shaking (120 rpm) over 
indicated periods of time (2, 4, 6, and 8 weeks). PBS solution was refreshed weekly to 
keep a constant pH of 7.4. 
 
 
 
 
Figure  3.6. The incubator (Edmund Bühler GmbH) used in this study. 
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Three samples of each group were removed from PBS at predetermined intervals, rinsed 
with distilled water and air dried in the oven at 40°C for 24 h before weight loss 
determination. The weight loss ( ௟ܹ௢௦௦) of specimens was calculated via following 
equation: 
 
௟ܹ௢௦௦ 	(%) = ൤ ଵܹ − ଶܹ
ଵܹ
൨ × 100 
 
where ଵܹ and ଶܹ are the composite weight before and after degradation, respectively. The 
results reported are averages of three measurements and standard deviations were 
calculated.  
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4.1 Gelation Behaviour of Chitosan-based Systems 
 
The evolution of rheological parameters (Gʹ and Gʹʹ) of chitosan solutions with different 
added amounts of reticulation agents (Table  4.1) and subjected to a temperature sweep 
(25ºC  90ºC, 3ºC min1) under constant oscillation conditions (frequency = 1 Hz, strain = 
103) are shown in Figure  4.1.  
 
 
 
 
Figure  4.1. Temperature sweep for chitosan solution cross-linked with different 
concentrations of genipin (GP) and glutaraldehyde (GT) at different concentrations. 
 
 
The curves show an initial slightly decreasing tendency with temperature increasing up 
to minima values that depend on the added amount and type of cross-linker used. This 
decreasing trend, attributed to a reduction of viscosity of the solutions with temperature 
rising, is followed by gradual and then abrupt slop increases as temperature further 
increases.  This last steep increase of Gʹ and Gʹʹ is observed within the 60  80ºC range and 
corresponds to the temperature-induced reticulation of the systems. For a given added 
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amount of cross-linking agents, reticulation reactions seem to systematically occur slightly 
earlier in the presence of GT in comparison to GP.  
The evolution of Gʹ and Gʹʹ for systems with added FastOs®BG-Z4 powder in the 
absence and in the presence of the same amounts of cross-linking agents tested for chitosan 
solutions are shown in Figure  4.2 and Figure  4.3, for GP and GT, respectively. Interesting 
features can be observed: the first descending branch of Gʹ and Gʹʹ curves observed in 
Figure  4.2 was eliminated in the presence of FastOs®BG-Z4 powder, and reticulation 
occurred faster than when chitosan solutions with added cross-linking agents were tested. 
These features can be attributed to an active reticulation role played by the surface of 
FastOs®BG-Z4 particles and/or by its ionic species leached to the solution.  
 
 
 
 
Figure  4.2. Temperature sweep for chitosan/FastOs®BG-Z4 systems cross-linked with 
different amounts of GP. 
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Figure  4.3. Temperature sweep for chitosan/FastOs®BG-Z4 systems cross-linked with 
different amounts of GT. 
 
 
These observations suggest the occurrence of specific and synergetic interactions among 
chitosan molecules, the surface of FastOs®BG-Z4 particles and/or its ionic species leached 
to the solution, and the GT and GP species, which should be responsible for the observed 
faster gelation process. These amazing findings also suggest the possibility of preparing 
self-reticulation chitosan/FastOs®BG-Z4 composite scaffolds for tissue engineering, thus 
avoiding the use of potentially cytotoxic cross-linkers such as GT [57] [58].  
This hypothesis is confirmed by the gelation temperatures estimated from all the 
temperature sweep tests, which are summarized in Table  4.1. It can be seen that for a given 
added amount of cross-liking agents, the gelation temperature of chitosan solutions was 
always slightly lower for GT in comparison with GP, an observation that is in good 
agreement with the findings reported elsewhere [75]. For composite systems, gelation 
always occurs at lower temperatures in comparison to the chitosan solutions, even in the 
absence of cross-liking agents. These findings open further research avenues that need to 
be explored in future studies. Gelation temperature further decreases with added GP and 
GT, being lowest in the presence of GT due to its enhanced reticulation ability.  
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Table  4.1. Estimated gelation temperatures based on temperature sweep measurements. 
 
Gelation Temperature (C) 
Chitosan solutions 
With added GP 
GP01 ~ 79 
With added GT 
GT01 ~ 76 
GP05 ~ 74 GT05 ~ 67 
GP50 ~ 66 GT50 ~ 64 
Composite systems 
With added GP 
GP00 ~ 50 
With added GT 
GT00 ~50 
GP01 ~ 47 GT01 ~ 47 
GP05 ~ 43 GT05 ~ 30 
GP50 < 25 GT50 < 25 
 
 
Since the control the water evaporation was difficult even when using a "solvent trap", 
60ºC was selected as testing temperature for subsequent rheological characterization tests 
conducted under isothermal conditions.  
The gelling behaviours of chitosan solutions with different added amounts GP and GT 
are compared in Figure  4.4, while the evolution of Gʹ and Gʹʹ for the system with added 
FastOs®BG-Z4 alone is shown in Figure  4.5. 
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Figure  4.4. Time sweep profiles at 60C for chitosan solution cross-linked with different 
added amounts of GP and GT. 
 
 
 
 
Figure  4.5. Time sweep profile at 60ºC for chitosan/FastOs®BG-Z4 system. 
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It can be seen that at this relatively high temperature (60ºC), reticulation started 
immediately eliminating any descending trend of Gʹ and Gʹʹ derived from temperature 
dependent solution viscosity, and gelation times became shorter and shorter with 
increasing contents of GP and GT. It is also obvious from these Figures that initially Gʹ < 
Gʹʹ, with both Gʹ and Gʹʹ tending to increase with increasing setting time, but Gʹ increases 
faster than Gʹʹ, thus leading to gelation.  
The time sweep profile at 60ºC for the chitosan/FastOs®BG-Z4 system in absence of 
any cross-liking agent occurs much faster that when starting from chitosan solutions with 
different added amounts of GP and GT, as shown in Figure 4.5. Moreover, the maximum 
values of elastic modulus (Gʹ) measured for this system are about two order of magnitude 
higher in comparison to the corresponding ones obtained from the chitosan solutions in the 
presence of the cross-liking agents. The estimated gelation times of chitosan solutions 
(Table  4.2) decrease with increasing added amounts of cross-liking agents. For a given 
cross-liking content, gelation times are always shorter for GT, confirming its enhanced 
reticulation ability in comparison to GP. No crossover point could be detected for the 
composite system within the experimental time frame along which Gʹ and Gʹʹ were 
measured, suggesting that cross-linking has already occurred before starting the 
rheological measurements. 
 
 
Table  4.2. Gelation times at 60ºC for chitosan solutions cross-linked with different added 
amounts of GP and GT, and for the composite system without any cross-linking agent. 
 
Gelation time (min) at 60C (min) 
GP01 ~ 32 
GP05 ~ 31 
GP50 ~ 22 
GT01 ~ 12 
GT05 ~ 8 
GT50 ~ 6 
Chitosan/FastOs®BG-Z4 (50/50) Already cross-linked 
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The results showed that only relatively weak gels could be obtained by blending 2 wt.% 
chitosan solution with cross-linking agents up to 0.5 wt.%, while strong gels could be 
quickly achieved from the composite systems even in absence of cross-linking agents, 
although more efficiently in their presence. Therefore, it was concluded FastOs®BG-Z4 
powder has the ability to form complexes with dissociated chitosan molecules.  
Chitosan contains two different kinds of functional groups, hydroxyl (OH) groups and 
amino (NH2) groups, which are responsible for the reactivity of this polymer as an 
excellent natural adsorbent and give chitosan its powerful adsorptive capacity [76]. The 
surface adsorption mechanism would involve coulombic interactions between the positive 
amino groups of chitosan and the negative surface sites of FastOs®BG-Z4. Acidic pH is 
necessary for the protonation of amino (NH3+) groups of chitosan. These protonated 
groups are likely to bind to the negatively charged surface FastOs®BG-Z4. On the other 
hand, hydroxyl (OH) groups are also likely to form intermolecular hydrogen bonds with 
the surface silanol groups of FastOs®BG-Z4 powders, thus contributing to strengthen the 
composite gels. But the most probable gel strengthening mechanism, in the case of 
chitosan/FastOs®BG-Z4 composite systems, is a cationic exchange between protonated 
amino groups of chitosan and cationic sites onto the surface of the bioactive glass particles 
and/or the cationic species leached out to the solution as sketched below: 
 2	ܥℎ݅ݐܰܪଷା 	+ 	ܯଶା 	→ ܥℎ݅ݐܰܪଶܯܪଶܰܥℎ݅ݐ (1) 
 
A similar cationic exchange mechanism could be hypothesised for the replacement of 
two hydronium ions from different chitosan (ܥℎ݅ݐܱܪ) molecules by a divalent cation, 
which would involve a decrease in pH of the media:  
 
ܥℎ݅ݐܱܪ	 + 	ܪܱܥℎ݅ݐ	 + 		ܯଶା	2ܪଶܱ	 → 	ܥℎ݅ݐܱܯܱܥℎ݅ݐ	 + 	2ܪଷܱା (2) 
 
According to Rhazi et al. [77], the free amine function of chitosan confers it a better 
ability to chelate ions of transition metals. However, more investigations are required to 
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show further light on the reticulation mechanism involving the functional groups of 
chitosan and the surface of bioactive glass particles or the ionic species leached out to the 
solution.  
 
4.2 FTIR-ATR Spectroscopy Analysis 
 
Figure  4.6 shows the FTIR spectra within the 300–4000 cm−1 spectral range of 
FastOs®BG-Z4 powder, and of the chitosan/FastOs®BG-Z4 composite scaffolds reticulated 
without any added cross-linking agent, and with added 0.05 wt.% of GP or GT, all frozen 
at 20ºC. The aim was to identify which functional groups of chitosan would be involved 
in the reticulation processes undergone in the different experimental processing conditions. 
Unfortunately, only the limited number of samples referred above could be analysed. The 
spectra of LA solution and of LA+chitosan solution without and with added cross-liking 
agents need to be performed in future studies. 
 
 
 
Figure  4.6. FTIR spectra of FastOs®BG-Z4 and chitosan/FastOs®BG-Z4 composites cross-
linked with 0.05 wt.% of GP or GT and frozen at 20ºC. 
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The FTIR spectrum of FastOs®BG-Z4 exhibits three broad bands in the region of ~ 500 
– 1300 cm1. The most intense bands within the 600 – 1300 cm1 region correspond to the 
stretching vibrations of the SiO4 tetrahedron with a different number of bridging oxygen 
atoms. The 800–1300 cm1 region is split in two bands centred at ~1040 cm1 and ~920 
cm1, which can be assigned to the Si–O asymmetric stretching mode of BOs, and to the 
Si–O asymmetric stretching mode of the non-bridging oxygens (NBOs), respectively. 
Furthermore, the 510 cm1 band can be attributed to Si–O–Si bending modes, while the 
weak 740 cm1 shoulder may be due to Si–O–Si symmetric stretching with simultaneous Si 
cation motions. It is noteworthy that the band at 1040 cm1 may also be assigned to the 
asymmetric stretching of PO4 units which has been reported to appear in crystalline 
fluorapatite at 1038 cm1 [78]. 
The FTIR spectra of chitosan/FastOs®BG-Z4 composites exhibit characteristic bands of 
chitosan. The band in the region of 3400–3500 cm−1 corresponds to the stretching vibration 
of NH peaks at around 3480 cm−1 and might be also be superimposed with the absorption 
band due to OH group. The peaks at around 2916 cm−1 and 2848 cm−1 are assigned to CH2 
and CH3 groups (aliphatic group). The bands at ~1660 cm−1 and ~1585 cm−1 are 
characteristic of respectively amide I and amide II, denoting the presence of acetyl group 
(CH3C=O), so these results confirm that chitosan is partially in deacetylated form. The 
peaks around 1420 cm−1 are assigned to the CH3 symmetrical deformation mode, and the 
peaks in the range of 1155 cm−1, 1097 cm−1 and 1043 cm−1 correspond to the CO 
stretching vibrations. Table  4.3 summarizes the FTIR data, identifying the main vibration 
bands and the corresponding assigned functional groups. The mentioned characteristic 
bands are in good agreement with data previously reported [79] [80]. 
The spectra of chitosan/FastOs®BG-Z4 composite systems cross-linked with GP or GT 
also show similar absorption bands as those identified for the composite system in absence 
of cross-liking agents. This suggests that the most determinant reticulation mechanisms 
derive from the interactions between chitosan molecules and the surface of bioactive glass 
particles and/or the ionic species leached thereof, with the cross-linking agents GP and GT 
playing secondary roles. This main conclusion is consistent with the rheological results 
presented in Figure  4.1 Figure 4.5, and data reported in Table  4.1 Table 4.2.  
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Table  4.3. Infrared frequencies of functional groups for FastOs®BG-Z4, and chitosan/ 
FastOs®BG-Z4 composite systems without and with adder 0.05 wt.% of GP or GT. 
 
Wavenumber (cm1) 
FastOs®BG-Z4 GP(GT)00, GP05, GT05  
600–1300 SiO4 3480 N-H 
1040 Si–O PO4 2950 OH 
920 Si–O 2916 CH2 
740 Si–O–Si 2848 CH3 
510 Si–O–Si 1660 amide I 
  1585 amide II 
  1420 CH3 
  1155 C-O 
  1097 C-O 
  1043 C-O 
  750 amide V 
  528 CH3 
 
 
4.3 Microstructural Analysis 
 
The microstructure of chitosan/FastOs®BG-Z4 composites without and with added 0.01, 
0.05, and 0.5 wt.% of GP or GT and frozen at 20ºC are shown in Figure  4.7 Figure 4.8. 
The SEM micrographs show high porosity with almost interconnected spherical pores in 
irregular pattern. Both the cross-linking concentration and freezing temperature seemingly 
affected the final porous structures of the scaffolds. Irregular porosity is mostly caused by 
the freeze drying and sample preparation conditions. The pores are created by the ice 
crystals that sublimate during freeze drying, leaving gaps or pores in their place. The pore 
structure corresponds to the size and shape of the ice crystals. 
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Figure  4.7. SEM micrographs of chitosan/FastOs®BG-Z4 composites frozen at 20ºC, without (a, b) and 
with different added amounts of GP (c, d) GP01, (e, f) GP05, (g, h) GP50. 
a b 
c d 
e f 
g h 
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Figure  4.8. SEM micrographs of Chitosan/FastOs®BG composites frozen at 20ºC, without (a, b) and with 
different added amounts of GT (c, d) GT01, (e,f) GT05, (g, h) GT50. 
a b 
c d 
e f 
g h 
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For composites cross-linked with GP and frozen at 20ºC, Figure  4.7 shows that pore 
size gradually decreased from 118  35 m for 0.01 wt.% GP to 74  28 m for 0.5 wt.% 
GP, although the internal connectivity has been maintained. This evolution can be 
understood considering that an enhanced reticulation is likely to led to finer 3D porous 
network, and is in line with other findings reported before [73] [81]. However, there is not 
a complete consensus in these matters. For example, the groups of Bi [72] and Gorczyca 
[82] reported an increase of pore size with increasing amounts of added GP used to cross-
link chitosan-collagen scaffolds. Our observations when using GP also contrast with an 
opposite evolution observed for the composites cross-linked with GT (Figure 4.8) in which 
the pore size increased from 72  16 m to 119  30 m as the GT concentration increased 
from 0.01 to 0.5 wt.%. All these results suggest that the pore structure is affected not only 
by the type and added amount of cross-linking agent but also by other experimental factors 
such as reticulation and freezing temperatures for polymeric solutions, and the presence 
inorganic components or dissolves species, the separate effects of which need to be better 
understood. 
The effect of freezing temperature can be evaluated by comparing the SEM micrographs 
shown in Figure  4.9 Figure 4.10, which correspond to chitosan/FastOs®BG-Z4 composite 
scaffolds frozen at 20ºC and 80ºC, respectively. It is clear that scaffolds frozen at 20ºC 
have a more opened and spaced structure. The formation of a highly closed tight network 
of scaffolds at 80ºC could be explained as a result of faster gelation, which resulted in the 
formation of smaller ice crystals and restricted more their growth along the holding time at 
this temperature. At 20ºC the growth of ice crystals is facilitated by the higher kinetic 
energy of water molecules for diffusion. 
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Figure  4.9. SEM micrographs of chitosan/FastOs®BG-Z4 composite scaffolds cross-linked with 
different added amounts of GP (a, b) GP01, (c, d) GP05, (e, f) GP50, frozen at 20ºC and 80ºC. 
 
 
 
 
 
 
 
a b 
d c 
e f 
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Figure  4.10. SEM micrographs of chitosan/FastOs®BG-Z4 composite scaffolds cross-linked with 
different added amounts of GT (a, b) GT01, (c, d) GT05, (e, f) GT50, frozen at 20ºC and 80ºC. 
 
a b 
d c 
e f 
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4.4 Cross-linking Degree Determination  
 
The chitosan/FostOs®BG-Z4 composite scaffolds cross-linked with GT exhibited a 
white colour, contrasting with the typical light bluish colour obtained for those cross-
linked with GP, especially with the highest added amount (GP50), as shown in Figure  4.11. 
 
 
 
 
Figure  4.11. Chitosan/FastOs®BG-Z4 scaffolds cross-linked with (a) GP and (b) GT. 
 
 
The cross-linking degree (CD) was determined by the ninhydrin assay [83] [84]. The 
concentration of free amino (NH2) groups in the sample was determined from a standard 
curve of the glycine concentration versus absorbance (Figure  4.12). 
 
 
 
 
 
 
 
 
(a) (b
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Figure  4.12. Standard calibration curve of glycine for determining unknown 
concentrations of ninhydrin. 
 
 
The results of cross-linking degrees determined by this method are reported in 
Table  4.4. It can be seen that cross-linking degrees increased with increasing added 
amounts of GP or GT. These results confirm that GP is a less efficient cross-linker in 
comparison to GT, in good consistency with the finding from rheological measurements. It 
can be also concluded that cross-linking degree was independent of freezing temperature, 
in agreement with similar observations reports elsewhere [83] [84]. 
 
 
Table  4.4. Cross-linking degree for chitosan/FastOs®BG-Z4 scaffolds promoted by different 
added amounts (wt.%: 0.01; 0.05; and 0.5) of GP or GT. 
 
Genipin CD (%) Glutaraldehyde CD (%) 
GP01 45.5  2.7 GT01 60.2  2.1 
GP05 49.2  2.4 GT05 65.3  2.0 
GP50 60.2  2.5 GT50 76.2  3.0 
0.000
0.002
0.004
0.006
0.008
0.010
0 2 4 6
A
bs
or
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e
Concentration (mg/ml)
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With a deacetylation degree of chitosan ≥ 85%, mean that about 85% of the repeating 
units of a chitosan chain have an amine group. According to the results, neither GP nor GT 
did utilize all available amino groups at the tested concentrations and chitosan has not been 
completely cross-linked. However, GT is again confirmed to be the most efficient one. Its 
capability to cross-link amine containing polymers by forming amine–amine bonds, so-
called Schiff bases, to improved mechanical properties of scaffolds and decrease chitosan 
degradation in biological tissues has been widely acknowledged [85] [75]. The different 
cross-linking efficiencies might help explaining the differences observed in SEM 
micrographs of Figure 4.1 Fugure 4.5, and data reported in Table 4.1 Table 4.2.  
On the other hand, GP consisting of a simple aromatic ring is not likely to produce 
hydrophobic p-stacking interactions with chitosan and, consequently, has a lower 
capability to cross-link chitosan matrix in the tested condition as compared with GT [75]. 
Figure  4.13 shows the schematics of chitosan cross-linking with GP and GT under near 
neutral conditions (pH ~ 6.8) [75]. 
 
 
 
 
 
 
Figure  4.13. Schematic representations of the most probable chemical reactions involved at the site 
of free amino groups of chitosan under near neutral conditions (pH ~6.8) with (a) GP, and (b) GT 
[75]. 
 
(a
(b
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According to Kil’deeva et al. [80], the reactivity of GT with amino groups of chitosan is 
different at different pH values. They have shown that in weakly acidic and neutral 
solutions (pH 3.0–7.2), no oligomerization is promoted by GT. At pH ≥ 5.6, the 
dissociation of a proton from the OCHCH2 leads to the formation of an anion, the first 
stage of the aldol reaction. In a weakly alkaline medium (pH > 7.2) such as in the present 
work, GT is polymerized and the products of the aldol reaction and aldol condensation are 
formed, in which the polymerization rate increases with the concentration of hydroxyl ions. 
Increasing the pH value above 10 leads to the formation of water-soluble and -insoluble 
polymeric products of the aldol reaction and the condensation of GT. 
In fact, the crosslinking is facilitated by formation of many irregular oligomeric 
glutaraldehyde molecules in which one aldehyde group of glutaraldehyde can react with 
chitosan while the other aldehyde group can undergo polymerization and eventually form 
bonds with other chitosan molecules. The mechanism leads to formation of a cross-linked 
structure with longer intermolecular chain lengths than would have been expected from 
monomeric glutaraldehyde. Formation of self-polymerized glutaraldehyde compounds, and 
their influence on chitosan cross-linked structures has been reported in details in some 
previous works [80] [86]. 
The cross-linking reaction mechanisms for chitosan with GP are also pH dependent. 
Under acidic and neutral conditions, a nucleophilic attack by the amino groups of chitosan 
on the olefinic carbon atom at C-3 occurs, followed by opening the dihydropyran ring of 
GP and attacked by the secondary amino group on the newly formed aldehyde group. In 
the product, short chains of condensed GP act as cross-linking bridges. Under basic 
conditions, the ring-opening reaction of GP occurs via a nucleophilic attack by hydroxyl 
ions in aqueous solution to form intermediate aldehyde groups, which subsequently 
undergo aldol condensation. The terminal aldehyde groups on the polymerized GP undergo 
a Schiff reaction with the amino groups on chitosan to form cross-linked networks. 
Therefore, the pH condition plays an important role in influencing the cross-linking 
reactions [87], which is linked to the available number of free amino groups in solution.  
Under acidic environments the amino groups are essentially protonated and their 
participation in cross-linking process is more limited. As pH of solution increases, the 
number of free amino groups also increases leading to a consequent reduction in gelation 
time. This phenomenon is true for both GT and GP.  
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4.5 Pore Size and Porosity Measurement 
 
In this study, pore sizes and porosity fractions of the composite scaffolds were 
evaluated using cylindrical samples of (2.4 cm diameter × 0.9 cm height) immersed into 
ethanol. The porosity values reported in Table  4.5 vary within the range of 80-92% 
depending on freezing temperature and cross-liking agent used.  
 
 
Table  4.5. Porosity of chitosan/FastOs®BG membranes cross-linked with 
genipin and glutaraldehyde. 
 
Composite 
Porosity (%) 
(20ºC) (80ºC) 
GP00/GT00 85.0  2.2 80.0  1.7 
GP01 92.0  1.0 90.0  1.3 
GP05 90.0  1.5 88.0  2.0 
GP50 86.0  1.7 82.0  2.3 
GT01 88.0  1.2 85.0 1.0 
GT05 85.0  1.1 83.0 1.8 
GT50 84.0  1.5 80.0 2.0 
 
 
The lowest values were obtained for composite scaffolds reticulated without any added 
cross-liking agents, followed successively by those cross-liked with GT and GP. These 
results are very consistent with other data reported above, namely the obtained by 
rheological measurements (Figure 4.1 Figure 4.5, and Tables 4.1 Table 4.2) and cross-
liking degrees (Table  4.4). All these results point out to an apparent enhanced reticulation 
efficiency of chitosan with added FastOs®BG-Z4 powder in comparison to the chitosan 
solutions with added GT and GP. For an easier visualization, the porosity data of 
composites scaffolds cross-linked with GP and GT have also been plotted in Figure  4.14 to 
Figure 4.17 aiming at better comparing the separate effects of cross-likers and freezing 
temperatures.  
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Figure  4.14. Percentage of porosity of composite scaffolds frozen at 20ºC cross-
linked by GP or GT. 
 
 
 
 
Figure  4.15. Percentage of porosity of composite scaffolds frozen at 80ºC cross-
linked by GP or GT. 
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Figure  4.16. Effect of freezing temperature on the percentage of porosity of 
composite scaffolds cross-linked GP. 
 
 
 
Figure  4.17. Effect of freezing temperature on the percentage of porosity of 
composite scaffolds cross-linked GT. 
 
 
 
From Table  4.5 and Figure 4.14 to Figure 4.17, it can be clearly seen that under all the 
reticulation conditions tested, the composite scaffolds frozen at 80ºC are systematically 
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less porous in comparison to the samples frozen at 20ºC, an observation that is consistent 
with the more favourable temperature induced growing of ice crystals at 20ºC, and with 
the microstructural features observed in SEM micrographs (Figure  4.7 to Figure  4.10). The 
overall results observed in the present work are in good agreement with findings reported 
by Shirosaki [88], Ren [89], Kang [90] and Ho [91]. 
The larger pores will provide space for the migration of cells and to improve the 
diffusion of nutrients and metabolites throughout the membrane [81]. Some reports point 
out that multi-channel conduits with relatively higher porosity and greater average channel 
diameters could provide a more permissive environment for axonal ingrowth than those 
having lower porosity and smaller average channel diameters [92] [93]. The adhesion and 
proliferation of cells are influenced by porosity so this is a decisive factor for absorption 
ability of scaffolds. High porosity and interconnectivity pore structure are necessary for 
tissue-guided scaffold materials. The pore diameter should be in the range of cell diameters 
to enable cell infiltration and vascularization of the scaffold [94]. Chitosan membranes 
with about 90% porosity and average pore size of ~110 m were reported to significantly 
improve nerve fibre regeneration and the degree of functional recovery [95]. In other study 
done by Wan et al. [96] the porosity and average channel diameter of the conduits were 
respectively set as around 80% and 200 m by controlling processing parameters with 
required mechanical strength and degradation rates. In addition, it has also been observed 
that the channels inside conduits would be blocked due to swelling of the conduits if the 
channel diameters are too small, resulting in no nerve growth in the blocked conduits [93]. 
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4.6 Mechanical Properties 
 
Hydrated porous chitosan/FastOs®BG-Z4 composite scaffolds were soft, spongy and 
very flexible. No maximum compression strength was obtained because the scaffolds did 
not break when subject to compression up to strain values of ~60%, the maximum value 
used for all the samples. The date plotted in Figure  4.18 Figure  4.21 are intended to 
convey an easy visualization of the separate effects of added cross-likers and freezing 
temperatures on the mechanical properties of chitosan/FastOs®BG-Z4 composite scaffolds.  
Generally, the mechanical compressive strength values of the cross-linked chitosan 
scaffolds always increases with increasing added amounts of cross-linking. The only 
exception was observed for the highest added amount of GT. This deviation from the main 
trend can be attributed to the concomitant increase of the average size of pores formed 
under these conditions. The smaller average pore sizes formed in samples frozen at 80ºC 
can also explain the systematically higher compressive strength values registered for these 
samples in comparison to those obtained from samples frozen at 20ºC. The same 
argument is also valid when comparing the compressive strength values of composite 
scaffolds reticulated with different cross-linking agents. The higher percentages of porosity 
measured for scaffolds cross-linked with GP (Table  4.6), coupled with the larger pores 
observed for these scaffolds (Figure  4.7 and Figure  4.8) support the registered compressive 
strength data plotted in Figure  4.18 Figure 4.21. 
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Figure  4.18. Compressive strength of chitosan/FastOs®BG-Z4 composite 
scaffolds cross-linked with GP. 
 
 
 
Figure  4.19. Compressive strength of chitosan/FastOs®BG-Z4 composite scaffolds 
cross-linked with GT. 
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Figure  4.20. Compressive strength of chitosan/FastOs®BG-Z4 composite 
scaffolds cross-linked with GP and GT frozen at 20ºC. 
 
 
 
 
 
Figure  4.21. Compressive strength of chitosan/FastOs®BG-Z4 composite scaffolds 
cross-linked with GP and GT frozen at 80ºC. 
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Another interesting and expected feature is the increasing trend observed for 
compressive strength with increasing strains. To better illustrate such evolution 
compressive strength values were registered for all composite scaffolds at strains of 20%, 
40%, and 60%. The date was plotted in Figure  4.22 Figure  4.25. These results confirm the 
above referred general increasing trend of compressive strength with increasing added 
amounts of cross-liking agents, at both freezing temperatures (20ºC and 80ºC), with the 
exception of the highest amount of GT (Figure  4.24 and Figure 4.25) that led to the 
formation of larger pores as confirmed by the SEM micrographs (Figure  4.8 and Figure 
4.10). 
 
 
 
 
Figure  4.22. Evolution of compressive strength with strain for composite scaffolds 
frozen at 20ºC, cross-linked without and with different added amounts of GP. 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
20 40 60
C
om
pr
es
si
ve
 s
tr
en
gt
h 
(k
Pa
)
Strain (%)
GP00-20
GP01-20
GP05-20
GP50-20
Results and Discussion 71 
 
 
 
 
 
 
 
Figure  4.23. Evolution of compressive strength with strain for composite scaffolds 
frozen at 80ºC, cross-linked without and with different added amounts of GP. 
 
 
 
 
Figure  4.24. Evolution of compressive strength with strain for composite scaffolds 
frozen at 20ºC, cross-linked without and with different added amounts of GT. 
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Figure  4.25. Evolution of compressive strength with strain for composite scaffolds 
frozen at 80ºC, cross-linked without and with different added amounts of GT. 
 
 
Many factors affect the gelling time and the final structural and mechanical properties 
of scaffolds made of polymers or of composite systems, including the concentration of 
constituting components and of cross-linking agents, the solvent composition, the 
processing (cross-linking and freezing temperatures), etc. [97] [98] [99]. The results 
reported above and in previous literature reports clearly indicate that compressive strength 
of porous scaffolds is mainly dependent on pore structure. The same arguments are valid 
for the elastic modulus values that were plotted in (Figure  4.26 to Figure 4.29).  
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Figure  4.26. Elastic modulus of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GP and GT, frozen at 20ºC. 
 
 
 
Figure  4.27. Elastic modulus of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GP and GT, frozen at 80ºC. 
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Figure  4.28. Elastic modulus of chitosan/FastOs®BG-Z4 composite scaffolds cross-linked 
without and with different added amounts of GP, frozen at 20ºC and 80ºC. 
 
 
 
Figure  4.29. Elastic modulus of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GT, frozen at 20ºC and 80ºC. 
 
 
It seems consensual that smaller pores and higher cross-linking degrees are helpful to 
enhance the biomechanical strength engineered constructs [72]. It is also recognized that 
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forces exerted by the surrounding tissues [100]. Hence, in order to yield ideal polymer 
scaffolds, the optimal crosslinking condition should be investigated.  
Nerve conduits with enough mechanical properties will resist muscular contractions and 
maintain structural support with enough space and stability to facilitate nerve regeneration 
[35]. The enhanced mechanical properties of chitosan/FastOs®BG-Z4 composite 
membranes will allow better shape stability in comparison to those made from chitosan 
alone, making them more promising for these biomedical applications. 
 
4.7 Swelling Behaviours 
 
The swelling ratio is an important index used to evaluate the structural stability of a 
biodegradable scaffold. The swelling should be moderate. If too great, the scaffold will 
swell much in vivo, decreasing the available space the biological processes to occur within 
the scaffold. If too poor, it will cause local hydropenia at the implanting site [49]. As 
shown in Figure  4.30 to Figure  4.33, the scaffolds with added cross-linking agents exhibit 
a higher swelling capacity in comparison to that obtained without cross-linkers.  
 
 
 
 
Figure  4.30. Swelling ratio of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GP, frozen at 20ºC. 
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Figure  4.31. Swelling ratio of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GP, frozen at 80ºC.  
 
 
 
 
Figure  4.32. Swelling ratio of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GT, frozen at 20ºC.  
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Figure  4.33. Swelling ratio of chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GT, frozen at 80ºC.  
 
 
The swelling data plotted in Figure  4.30 to Figure  4.33 show an abrupt initial increase 
of PBS solution uptake followed by an accentuated decreasing trend up to about 3 h, and 
then by a slow and steadily decreasing along the remaining testing time interval (up to 24 
h). It can be seen that the less swelling capacity was obtained in the absence of cross-liking 
agents, followed by the samples with the highest amounts of GP and GT. The differences 
observed among the samples are consistent with the measured percentages of porosity 
(Table 4.5). In addition, the volume or shape of all scaffolds scarcely changed during 
soaking in PBS. The scaffolds absorbed PBS solution without collapsing of the 3D pore 
structure. 
The swelling properties of porous chitosan-based scaffolds can be understood based on 
the hydrophilic and cationic character of this polymer. Besides porosity, cross-linking of 
chitosan can also change its hydrophilicity, which, in turn will further decrease the 
swelling ratio scaffold [101]. Therefore, it can be concluded that the swelling behaviour of 
the composite chitosan/FastOs®BG-Z4 membranes and their mechanical stability are 
mostly determined by the porous structure and the relevant factors behind it (the kind and 
the added amount of cross-linker, and processing temperatures). Similar conclusions were 
drawn by Bi et al. group [72] for chitosan scaffolds.  
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4.8 Degradation Behaviours 
 
The degradation rate is another important index for the evaluation of scaffolds. The 
weight loss (WL) of the chitosan/Fastos®BG-Z4 composite scaffold without any added 
cross-linking agent was used as a control to compare with the others cross-linked with 
different added amounts of GP or GT. 
The WL data of all the chitosan/Fastos®BG-Z4 composite scaffolds are presented in 
Figure  4.34 to Figure  4.37 as a function of immersion time.  
 
 
 
Figure  4.34. Percentage of weight loss for chitosan/FastOs®BG-Z4 composite scaffolds 
cross-linked without and with different added amounts of GP, frozen at 20ºC. 
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Figure  4.35. Percentage of weight loss for chitosan/FastOs®BG-Z4 composite scaffolds 
cross-linked without and with different added amounts of GP, frozen at 80ºC. 
 
 
 
 
Figure  4.36. Percentage of weight loss for chitosan/FastOs®BG-Z4 composite scaffolds 
cross-linked without and with different added amounts of GT, frozen at 20ºC. 
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Figure  4.37. Percentage of weight loss for chitosan/FastOs®BG-Z4 composite scaffolds cross-
linked without and with different added amounts of GT, frozen at 80ºC. 
. 
 
From these Figure 4.34 Figure 4.37, it can be seen that the degradation rates decrease 
with increasing added amounts of cross-linking agents at constant pH = 7.4, with the 
highest values being observed for the control sample reticulated without any added cross-
linker. Another important conclusion is that degradation rates are systematically slower for 
samples frozen at the lower freezing temperature (80ºC).  
This expected behaviour is eventually more easily observed when degradation data of 
chitosan/FastOs®BG-Z4 composite scaffolds cross-linked with GP or GT, collected after 
soaking for 8 weeks in PBS solution is plotted against the added amounts of cross-linking 
agents, as shown in Figure  4.38 and Figure  4.39.  
The results observed are according to the cross-linking degree detected by the NHN 
assay. The higher crosslinking degrees promoted by GT (Table  4.4) resulted in systematic 
lower weight losses. Regardless of the presence, or not, of cross-linking agents and of the 
weight losses undergone, all composite scaffolds maintained their structural integrity, an 
essential feature for successful applications in nerve repair. 
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Figure  4.38. Percentage of weight loss after 8 weeks soaking in PBS solution of chitosan/ 
FastOs®BG-Z4 composite scaffolds cross-linked without and with different added amounts of GP 
and GT, frozen at 20ºC. 
 
 
 
 
Figure  4.39. Percentage of weight loss after 8 weeks soaking in PBS solution of chitosan/ 
FastOs®BG-Z4 composite scaffolds cross-linked without and with different added amounts of GP 
and GT, frozen at 80ºC. 
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The results obtained along this Master thesis project enable a number of conclusions to 
be drawn, the most salient one is the disclosure for the first time that self-setting 
chitosan/FastOs®BG-Z4 porous composite scaffolds/membranes can be prepared by just 
adding the bioactive glass particles to the chitosan solutions. Although the 
setting/reticulation mechanism still demands further investigations to become fully 
understood, it was hypothesized that both active sites at the surface of bioactive glass 
particles and the ionic species leached off to the solution are likely to play a cross-liking 
role. These amazing findings mean that the use of potentially cytotoxic cross-linkers such 
as GT can be avoided, thus making the membranes for nerve regeneration innocuous and 
bio-friendly.  
Besides this main important achievement, several other specific conclusions can be 
drawn from the present work as detailed below: 
 
1. The naturally occurring genipin (GP) and the traditional synthetic glutaraldehyde 
(GT) revealed to be suitable cross-linkers for making 3D composite 
chitosan/FastOs®BG-Z4 porous membranes for nerve regeneration. The cross-linking 
efficiency and the consequent mechanical stability are generally higher in the case of 
GT in comparison to GP, except for the highest added amount of GT.  
 
2. The enhanced cross-linking efficiency of GT resulted in higher cross-linking 
degrees and systematic lower percentages of porosity and swelling ratios, and slower 
degradation rates upon immersion in PBS solution, as expressed by the undergone 
weight losses along a time period of 8 weeks. Accordingly, the higher degradation rates 
were observed for the self-reticulated porous chitosan/FastOs®BG-Z4 composite 
membranes. 
 
3. For both cross-linking agents used, the cross-linking degree always increased with 
the added amounts, within the range of concentrations tested, with direct reflexes in 
terms of the overall properties of the resulting scaffolds. 
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4. The lower freezing temperature (80ºC) revealed to be more effective in decreasing 
the pore size and porosity fraction, thus enhancing the mechanical properties and the 
stability of the scaffolds when submitted to swelling and degradation tests.  
 
5. The freezing temperature of 20ºC was selected as the most suitable one when 
considering the porous microstructural features and the intended applications. 
 
6. Regardless of the presence, or not, of cross-linking agents and of the weight losses 
undergone, all composite scaffolds maintained their structural integrity, an essential 
feature for successful applications in nerve repair. 
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The most salient finding of the present work opened further research avenues that need 
to be explored in future studies. The self-reticulation mechanism of chitosan/Fastos®BG-
Z4 needs to be investigated in detail in order to clarify the relative importance of the 
surface chemistry of the bioactive glass particles and of the dissolves ionic species. It 
would be also important studying the influence of different chitosan/Fastos®BG-Z4 weight 
ratios on the gelation process and on the overall properties of the resulting scaffolds.  
Obviously, testing the scaffolds in vitro for cytotoxicity, biocompatibility and cell 
proliferation, and in vivo are essential steps to be conducted in the future to evaluate the 
suitability of the composite membranes for the intended clinical applications as nerve 
guides in peripheral nerve regeneration. 
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